Malvern, PANalytical to Merge
Malvern and PANalytical are pleased to announce that effective 1 January 2017 they will be merging their activities. Both companies are owned by parent company Spectris plc and are operating companies within the Materials Analysis segment of Spectris.
Both companies are world leading suppliers of analytical instrumentation, PANalytical for X-ray instrumentation and software for the purpose of materials analysis and Malvern Instruments for materials and biophysical characterization technology. The combined entity is a strong player in the materials characterization market and will be able to leverage the strengths of the individual companies in their end markets ranging from building materials to pharmaceuticals and from metals and mining to nanomaterials. .
The merger is based on the belief that there are clear benefits through this more collaborative relationship, leveraging the very strong brands and highly-skilled employees of the two companies, in order to deliver a more complete range of products, solutions and services to a broader set of markets and customers.
The companies will be working together to ensure a smooth and effective integration guaranteeing our usual high level of support to all our customers. The combined group will continue to develop and invest in the Malvern and PANalytical technologies and the highly-talented workforce.
Eoghan O’Lionaird, Business Group Director responsible for the Materials Analysis segment within Spectris, says: “This is an exciting time for Malvern and PANalytical. Joining the two companies will enable us to leverage new resources to further grow our service offering and add even more value to our clients and customers. We are committed to ensuring a smooth integration process and will be actively engaging with our customers on how the combined entity can better serve their needs.”
Please note: The content above may have been edited to ensure it is in keeping with Technology Networks’ style and length guidelines.
Catalyst Can Degrade Alzheimer's-Related Amyloid Peptide Under Near-Infrared LightNews
A new, biocompatible photooxygenation catalyst that can selectively oxygenate and degrade the pathogenic aggregation of Alzheimer's disease (AD)-related amyloid-β peptide (Αβ) under near-infrared (NIR) light irradiation has been developed.READ MORE
Consuming Low-Calorie Sweeteners May Predispose Overweight Individuals to DiabetesNews
Consumption of low-calorie sweeteners could promote metabolic syndrome and predispose people to prediabetes and diabetes, particularly in individuals with obesity, a new study on human fat-derived stem cells and fat samples suggests.READ MORE
Comments | 0 ADD COMMENT
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018